Leggieri A, Garcia-Gonzalez J, Torres-Perez J, Havelange W, Hosseinian S, Mech A
Front Neurosci. 2022; 16:794653.
PMID: 35210987
PMC: 8861280.
DOI: 10.3389/fnins.2022.794653.
Lyon K, Rood B, Wu L, Senft R, Goodrich L, Dymecki S
eNeuro. 2020; 7(6).
PMID: 33214315
PMC: 7768286.
DOI: 10.1523/ENEURO.0202-20.2020.
Toth M, Gresack J, Hauger R, Halberstadt A, Risbrough V
Psychopharmacology (Berl). 2013; 229(4):579-89.
PMID: 23722830
PMC: 3784645.
DOI: 10.1007/s00213-013-3114-9.
Radke A, Gewirtz J
Neuropsychopharmacology. 2012; 37(11):2405-15.
PMID: 22692565
PMC: 3442355.
DOI: 10.1038/npp.2012.97.
Devoto P, Frau R, Bini V, Pillolla G, Saba P, Flore G
Psychoneuroendocrinology. 2011; 37(10):1630-45.
PMID: 22029952
PMC: 3432701.
DOI: 10.1016/j.psyneuen.2011.09.018.
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
Hong L, Thaker G, McMahon R, Summerfelt A, RachBeisel J, Fuller R
Arch Gen Psychiatry. 2011; 68(12):1195-206.
PMID: 21810630
PMC: 3618988.
DOI: 10.1001/archgenpsychiatry.2011.83.
Dopamine is necessary for cue-dependent fear conditioning.
Fadok J, Dickerson T, Palmiter R
J Neurosci. 2009; 29(36):11089-97.
PMID: 19741115
PMC: 2759996.
DOI: 10.1523/JNEUROSCI.1616-09.2009.
Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
Kinney G, Wilkinson L, Saywell K, Tricklebank M
J Neurosci. 1999; 19(13):5644-53.
PMID: 10377370
PMC: 6782328.
Effects of haloperidol and SCH 23390 on acoustic startle in animals depleted of dopamine as neonates: implications for neuropsychiatric syndromes.
Schwarzkopf S, Bruno J, Mitra T, Ison J
Psychopharmacology (Berl). 1996; 123(3):258-66.
PMID: 8833419
DOI: 10.1007/BF02246580.
D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.
Hoffman D, Donovan H
Psychopharmacology (Berl). 1994; 115(4):447-53.
PMID: 7871088
DOI: 10.1007/BF02245567.
Changes in the acoustic startle response and prepulse inhibition of acoustic startle in rats after local injection of pertussis toxin into the ventral tegmental area.
Zhang J, Engel J, Hjorth S, Svensson L
Psychopharmacology (Berl). 1995; 119(1):71-8.
PMID: 7675952
DOI: 10.1007/BF02246056.
5-Methoxy-N,N-dimethyltryptamine: spinal cord and brainstem mediation of excitatory effects on acoustic startle.
Davis M, Astrachan D, Gendelman P, Gendelman D
Psychopharmacology (Berl). 1980; 70(2):123-30.
PMID: 6776570
DOI: 10.1007/BF00435302.
Disruption of selective attention by apomorphine, but not amphetamine, in the Mongolian gerbil.
Cheal M
Psychopharmacology (Berl). 1980; 69(1):93-100.
PMID: 6771833
DOI: 10.1007/BF00426528.
Diethyldithiocarbamate depresses the acoustic startle response in rats.
Storm J, Millington W, Fechter L
Psychopharmacology (Berl). 1984; 82(1-2):68-72.
PMID: 6320250
DOI: 10.1007/BF00426383.
Cocaine: excitatory effects on sensorimotor reactivity measured with acoustic startle.
Davis M
Psychopharmacology (Berl). 1985; 86(1-2):31-6.
PMID: 3927365
DOI: 10.1007/BF00431680.
Effect of the dopamine receptor agonist apomorphine on sensory input.
Szechtman H
Naunyn Schmiedebergs Arch Pharmacol. 1988; 338(5):489-96.
PMID: 3244390
DOI: 10.1007/BF00179319.
Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.
Svensson L
Psychopharmacology (Berl). 1985; 85(4):469-75.
PMID: 3161114
DOI: 10.1007/BF00429667.
Apomorphine, d-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex.
Davis M
Psychopharmacology (Berl). 1988; 95(2):151-6.
PMID: 3137590
DOI: 10.1007/BF00174500.
Dopaminergic stimulation disrupts sensorimotor gating in the rat.
Mansbach R, Geyer M, Braff D
Psychopharmacology (Berl). 1988; 94(4):507-14.
PMID: 3131796
DOI: 10.1007/BF00212846.
Behavioral evidence implicating dopamine in sensorimotor arousal and norepinephrine in the sedative effects of antidepressant drugs.
Kokkinidis L, McCarter B
Psychopharmacology (Berl). 1990; 100(4):542-7.
PMID: 2320716
DOI: 10.1007/BF02244009.